XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.3
STOCKHOLDERS DEFICIENCY (Details 2)
 3 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
STOCKHOLDERS DEFICIENCY  
Number of Options Outstanding, Beginning | shares 2,263,440
Number of Options Expired | shares (14,338)
Number of Options Outstanding, Ending | shares 2,249,102
Number of Options Exercisable | shares 927,524
Number of Options Expected to vest | shares 1,321,578
Weighted Average Exercise Price Outstanding, Beginning $ 6.11
Weighted Average Exercise Price Granted 0
Weighted Average Exercise Price Forfeited 0
Weighted Average Exercise Price Exercised 0
Weighted Average Exercise Price Expired 7.92
Weighted Average Exercise Price Outstanding, Ending 6.12
Weighted Average Exercise Price Exercisable 10.81
Weighted Average Exercise Price Options Expected to vest $ 2.83
Weighted Average Remaining Term in Years Options outstanding at beginning of year 8 years 2 months 12 days
Weighted Average Remaining Term in Years Options outstanding at end of year 8 years
Weighted Average Remaining Term in Years Options exercisable at end of year 6 years 4 months 24 days
Weighted Average Remaining Term in Years Options Expected to vest 9 years 1 month 6 days
Aggregate Intrinsic Value Options Expected to vest | $ $ 0
Aggregate Intrinsic Value Options Expected to outstanding | $ 0
Aggregate Intrinsic Value Options Exercisable | $ $ 0